Live Breaking News & Updates on Analyst Recommendations For Longboard Pharmaceuticals

Stay updated with breaking news from Analyst recommendations for longboard pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Longboard Pharmaceuticals' (LBPH) "Buy" Rating Reiterated at HC Wainwright

Longboard Pharmaceuticals' (LBPH) "Buy" Rating Reiterated at HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Robertw-baird , Bourgeon-capital-management , Longboard-pharmaceuticals , Td-asset-management-inc , Citigroup , Longboard-pharmaceuticals-stock-performance , Denali-advisors , News-ratings-for-longboard-pharmaceuticals-daily , Analyst-recommendations-for-longboard-pharmaceuticals , Cantor-fitzgerald , Sg-americas-securities

HC Wainwright Reiterates "Buy" Rating for Longboard Pharmaceuticals (NASDAQ:LBPH)

HC Wainwright Reiterates "Buy" Rating for Longboard Pharmaceuticals (NASDAQ:LBPH)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Robertw-baird , Citigroup , Bourgeon-capital-management , Longboard-pharmaceuticals , Sg-americas-securities , Cantor-fitzgerald , Longboard-pharmaceuticals-company-profile , Institutional-investors-weigh-in-on-longboard-pharmaceuticals , Longboard-pharmaceuticals-inc , Asset-management-inc , Longboard-pharmaceuticals-stock

Cantor Fitzgerald Reaffirms "Overweight" Rating for Longboard Pharmaceuticals (NASDAQ:LBPH)

Cantor Fitzgerald Reaffirms "Overweight" Rating for Longboard Pharmaceuticals (NASDAQ:LBPH)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Robertw-baird , Td-asset-management-inc , Analyst-recommendations-for-longboard-pharmaceuticals , Bourgeon-capital-management , Longboard-pharmaceuticals , Jennison-associates , Hedge-funds-weigh-in-on-longboard-pharmaceuticals , Asset-management-inc , Cantor-fitzgerald , News-ratings-for-longboard-pharmaceuticals-daily , Citigroup

Wedbush Raises Longboard Pharmaceuticals (NASDAQ:LBPH) Price Target to $34.00

Wedbush Raises Longboard Pharmaceuticals (NASDAQ:LBPH) Price Target to $34.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Robertw-baird , Denali-advisors , Asset-management-inc , Cantor-fitzgerald , News-ratings-for-longboard-pharmaceuticals-daily , Citigroup , Longboard-pharmaceuticals-inc , Analyst-recommendations-for-longboard-pharmaceuticals , Jennison-associates , Longboard-pharmaceuticals , Platinum-investment-management-ltd

Cantor Fitzgerald Reiterates "Overweight" Rating for Longboard Pharmaceuticals (NASDAQ:LBPH)

Longboard Pharmaceuticals (NASDAQ:LBPH – Get Free Report)‘s stock had its “overweight” rating reiterated by investment analysts at Cantor Fitzgerald in a research note issued on Friday, Benzinga reports. They currently have a $60.00 target price on the stock. Cantor Fitzgerald’s price objective would indicate a potential upside of 178.68% from the company’s current price. Other […] ....

Robertw-baird , Longboard-pharmaceuticals-stock-performance , Longboard-pharmaceuticals , Parkman-healthcare-partners , Longboard-pharmaceuticals-company-profile , Td-asset-management-inc , Cantor-fitzgerald , Analyst-recommendations-for-longboard-pharmaceuticals , Bourgeon-capital-management , News-ratings-for-longboard-pharmaceuticals-daily , Denali-advisors